Search results
Results From The WOW.Com Content Network
The Global Fund’s investments have reduced deaths from HIV, tuberculosis, and malaria by 61% since 2002, saving 65 million lives. [27] Recent efforts include lowering the cost of key treatments for drug-resistant TB by 55% and first-line HIV medications by 25%, while introducing a more effective insecticide-treated mosquito net. [28]
The first Global Plan to Stop TB 2001-2005 provided a coherent agenda to rally key new partners, push forward research and development, and have a rapid impact on TB in the areas suffering most from the epidemic It focused on the emerging challenge of rising drug resistance in TB and HIV infection. The second Global Plan to Stop TB 2006-2015 ...
U.S. bilateral TB funding, managed by USAID, includes contributions to the TB Drug Facility and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Over the past decade, U.S. funding for TB has significantly increased, rising from $242 million in FY 2015 to $406 million in FY 2024, [ 18 ] now comprising about 3% of the U.S. global health ...
"Global Health: The Global Fund to Fight AIDS, TB and Malaria Is Responding to Challenges but Needs Better Information and Documentation for Performance-Based Funding" (PDF). U.S. GAO ~ GAO-05-639. U.S. Government Accountability Office. June 10, 2005. Archived (PDF) from the original on September 14, 2016
TB Alliance (formally The Global Alliance for TB Drug Development) is a not-for-profit product development partnership (PDP) dedicated to the discovery and development of new, faster-acting and affordable tuberculosis (TB) medicines.
The U.S. Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 [13] (or the Global AIDS Act) specified a series of broad and specific goals, alternately delegating authority to the president for identifying measurable outcomes in some areas, and specifying by law the quantitative benchmarks to be reached within discrete periods of ...
Since 2011, the president of the Global Health Program is Trevor Mundel: [136] The Global Fund to Fight AIDS, Tuberculosis and Malaria: The foundation has donated more than $6.6 billion for global health programs, including over $1.3 billion donated as of 2012 on malaria alone, greatly increasing the dollars spent per year on malaria research.
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.